Unlock instant, AI-driven research and patent intelligence for your innovation.

New human protein with cancer inhibiting function and its encoding sequence

A human protein and sequence technology, applied in the field of polypeptides encoded by polynucleotides, the use and preparation of polynucleotides and polypeptides, and can solve problems such as lack of functional genes and high throughput

Inactive Publication Date: 2005-07-06
NEWORGEN
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Human genomics research is currently a hot spot in the world. In addition to large-scale sequencing of human chromosome DNA and expressed sequence sequencing (EST), there is still a lack of high-throughput methods for screening functional genes starting from function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Example 1: Obtaining of cDNA gene and its inhibitory effect on mouse NIH / 3T3 cell clone formation

[0086] FP3361, FP7072 and FP8080 were derived from human fetal cDNA libraries constructed by conventional methods. Fetal tissues aged 3, 6, and 9 months were taken, and total RNA was extracted with Trizol reagent (GIBCO BRL Company) according to the manufacturer's instructions, and mRNA was extracted with an mRNA purification kit (Pharmacia Company). The cDNA library of the above mRNA was constructed with the pCMV-script TMXR cDNA library construction kit (Stratagene). The reverse transcriptase was changed to MMLV-RT-Superscript II (GIBCO BRL), and the reverse transcription reaction was carried out at 42°C. The XL 10-Gold competent cells were transformed, and a cDNA library with a titer of 1×106cfu / μg was obtained. In the first round, cDNA clones were randomly selected, and then high-abundance cDNA clones and cDNA clones that had been proven to inhibit the growth of can...

Embodiment 2

[0089] Example 2: Obtain full-length gene by PCR from placenta or fetal cDNA:

[0090] Fetal tissues (FP clones) aged 3, 6, and 9 months were taken, and total RNA was extracted with Trizol reagent (GIBCO BRL Company) according to the manufacturer's instructions, and mRNA was extracted with an mRNA purification kit (Pharmacia Company). Use MMLV-RT-Superscript II (GIBCO BRL) and reverse transcriptase to perform reverse transcription at 42°C to obtain placental or fetal cDNA. Use the specific primers for each gene (as shown in the table below), at 97°C 3', 1 cycle. 94°C 30", 60°C 30", 72°C 1', a total of 35 cycles; 72°C 10', 1 cycle for PCR amplification to obtain the amplification products of each protein gene containing the complete open reading frame sequence. The amplified product was verified by sequencing and was consistent with the sequence measured in Example 1, and then the amplified product was transferred into host cells using conventional techniques to obtain recombi...

Embodiment 3

[0093] Embodiment 3: cDNA clone sequence analysis

[0094] 1. FP3361 protein

[0095] A: Nucleotide sequence (SEQ ID NO: 1) length: 3046 bases

[0096] 1 GGTTTCACCA TGATGGTCAG GCTGGTCAAG ATCTCCTGAC CTCAAGTGAT CTGCCCGCCT

[0097] 61 CGGCCTCCCA AAGTGCTGGG ATTACAGACA TGAACCACAA CACCTGCCAA GCCCAGGTGT

[0098] 121 TTTGAATCCA GCACGGGCAA TGGCAAGACC CTGTCCCAAC AAACAAAAAA ACACTGGTGC

[0099] 181 CTGAGGCCCA CCCCGAGAGA TTCTGATTGA GTTGATTTGG ATTTGAATTA TCTTTAAAAT

[0100] 241 TTTGGATGTG AATTTTTTTTT TTTTTTCTTG GAATGGAGTT TCACTCTTGT TCCCCAGGCT

[0101] 301 GGAGTGCAAC GGGACGATCT TGGCTCACCG CAACCTCCGC CTACTGGGTT CAAGCCATTC

[0102] 361 TCCTGCCTCA GCTTCCCAAG TAGCTGGGAT TACAGGCATG TGCTACCATG CCCAGCTAAT

[0103] 421 TTTGTATTTT TAGTAGAGAC AGGGTTTCTC CATGTTGCTC AGGCTGGTCT TGAACTCCTG

[0104] 481 ACCTCAGGTG ATCCGCCCGC CTCGGACTCC CAAAGTGCTG GGATTACAGG CATGAGCCAC

[0105] 541 CATGCCTGGC CGGATGTGAA TTATCTTAAA AATTTTCAGG TAATTCTAAT GGGCCAAGGT

[0106] 601 TGAGAACCCC TGCTCTGGGC CC...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new type of human protein with tumor suppressor function, a polynucleotide encoding the polypeptide and a method for producing the polypeptide by recombinant technology. The present invention also discloses a method for the polypeptide to be used in the treatment of various diseases such as cancer. The invention also discloses the antagonist against this polypeptide and its therapeutic effect. The invention also discloses the use of the polynucleotide encoding this new human protein with tumor suppressor function.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular, the invention relates to a new polynucleotide encoding a human protein with tumor suppressor function and a polypeptide encoded by the polynucleotide. The present invention also relates to the use and preparation of such polynucleotides and polypeptides. Background technique [0002] Human genomics research is currently a hot spot in the world. In addition to large-scale sequencing of human chromosomal DNA and expressed sequence sequencing (EST), there is still a lack of high-throughput methods for screening functional genes starting from function. [0003] Cancer is one of the major diseases that endanger human health. In order to effectively treat and prevent tumors, people have paid more and more attention to gene therapy of tumors. Therefore, there is an urgent need in this field to develop and study human proteins with tumor suppressor functions and their agonists / inhibitors. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/17A61P35/00C07H21/00C07K14/435C07K14/47C07K16/18C12N15/12C12N15/63C12N15/64C12P21/02
Inventor 顾健人杨胜利
Owner NEWORGEN